Home
Conditions
Carcinoma, Squamous Cell

Clinical trial condition

Carcinoma, Squamous Cell

Explore clinical trials studying Carcinoma, Squamous Cell. Study availability and eligibility vary by location and protocol.

1,631 public trials 442 recruiting studies

Refine in advanced search Browse all conditions

Carcinoma, Squamous Cell trial results

Completed

PBI-MST-01 (NCT04541108) Substudy MSD-03: Intratumoral Microdosing of Pembrolizumab Alone and With MK-0482 or MK-4830 in HNSCC or STS

NCT06413095

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +9 more
Locations: UC Davis Sacramento, California, United States

Emory Winship Cancer Institute Atlanta, Georgia, United States

LSU Health Sciences Center - Shreveport Shreveport, Louisiana, United States

Montefiore Medical Center The Bronx, New York, United States

View Trial Details

Completed

Standard and Delayed FDG PET/CT After Chemoradiation Therapy in Assessing Patients With Metastatic Head and Neck Squamous Cell Cancer

NCT03575949

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +7 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Comparison of Concomitant Cisplatin Versus Carboplatin and 5-fluorouracil With Radiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma

NCT02778191

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +6 more
Locations: VUmc Amsterdam, Netherlands

University Medical Center Groningen Groningen, Netherlands

View Trial Details

Completed

The Sinai Robotic Surgery Trial in HPV Positive Oropharyngeal Squamous Cell Carcinoma (SCCA) (SIRS TRIAL)

NCT02072148

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +7 more
Locations: Mount Sinai Beth Israel New York, United States

Icahn School of Medicine at Mount Sinai New York, United States

View Trial Details

Completed

Window of Opportunity Study of Preoperative Immunotherapy With Atezolizumab in Local SCCHN

NCT04939480

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +5 more
Locations: University Hospital Essen Essen, Germany

View Trial Details

Completed

FRAIL-IMMUNE (GORTEC 2018-03) - Combination of Durvalumab With Carboplatin/Paclitaxel

NCT03723967

Conditions: Carcinoma, Carcinoma, Squamous Cell, Disease Attributes, +10 more
Locations: CHU d'Amiens Amiens, France

ICO - Centre Paul Papin Angers, France

Institut Sainte-Catherine Avignon, France

Centre Georges-François Leclerc Dijon, France

View all 17 locations

View Trial Details

Completed

10-year Retrospective Study of Oral and Maxillofacial Squamous Cell Carcinoma

NCT06366906

Conditions: AI, Carcinoma, Carcinoma, Squamous Cell, +9 more
Locations: Sun yat-sen memorial hospital Guangzhou, Guangdong, China

Sun yat-sun memorial hospital Guangzhou, Guangdong, China

View Trial Details

Completed

Fluciclovine F18 PET/CT in Identifying the Origin of Head and Neck Squamous Cell Carcinoma in Patients With Metastatic Cervical Nodal Disease

NCT03868020

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +7 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Abexinostat in Combination With Pembrolizumab in Patients With Advanced Solid Tumor Malignancies

NCT03590054

Conditions: Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +57 more
Locations: University of California, San Francisco San Francisco, California, United States

View Trial Details

Completed

Study of Anti-PD-L1 in Combination With Chemo(Radio)Therapy for Oesophageal Cancer

NCT02735239

Conditions: Adenocarcinoma Of Esophagus, Carcinoma, Carcinoma, Squamous Cell, +16 more
Locations: Research Facility Dundee, United Kingdom

Research Facility Nottingham, United Kingdom

Research Facility Oxford, United Kingdom

Research Facility Southampton, United Kingdom

View Trial Details

Carcinoma, Squamous Cell

Carcinoma, Squamous Cell trial results

Related conditions